These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18336745)

  • 21. Synergistic actions of pemphigus vulgaris IgG, Fas-ligand and tumor necrosis factor-alpha during induction of basal cell shrinkage and acantholysis.
    Orlov MD; Chernyavsky AI; Arredondo J; Grando SA
    Autoimmunity; 2006 Nov; 39(7):557-62. PubMed ID: 17101499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis is not required for acantholysis in pemphigus vulgaris.
    Schmidt E; Gutberlet J; Siegmund D; Berg D; Wajant H; Waschke J
    Am J Physiol Cell Physiol; 2009 Jan; 296(1):C162-72. PubMed ID: 18987254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transmembrane signaling for adhesive regulation of desmosomes and hemidesmosomes, and for cell-cell datachment induced by pemphigus IgG in cultured keratinocytes: involvement of protein kinase C.
    Kitajima Y; Aoyama Y; Seishima M
    J Investig Dermatol Symp Proc; 1999 Sep; 4(2):137-44. PubMed ID: 10536988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgG binds to desmoglein 3 in desmosomes and causes a desmosomal split without keratin retraction in a pemphigus mouse model.
    Shimizu A; Ishiko A; Ota T; Tsunoda K; Amagai M; Nishikawa T
    J Invest Dermatol; 2004 May; 122(5):1145-53. PubMed ID: 15140217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desmosomal adhesion and pemphigus vulgaris: the first half of the story.
    Cirillo N; Al-Jandan BA
    Cell Commun Adhes; 2013 Feb; 20(1-2):1-10. PubMed ID: 23368972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How does acantholysis occur in pemphigus vulgaris: a critical review.
    Lanza A; Cirillo N; Femiano F; Gombos F
    J Cutan Pathol; 2006 Jun; 33(6):401-12. PubMed ID: 16776715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro C3 mRNA expression in Pemphigus vulgaris: complement activation is increased by IL-1alpha and TNF-alpha.
    Feliciani C; Toto P; Amerio P
    J Cutan Med Surg; 1999 Jan; 3(3):140-4. PubMed ID: 10082594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris.
    Gil MP; Modol T; España A; López-Zabalza MJ
    Exp Dermatol; 2012 Apr; 21(4):254-9. PubMed ID: 22320676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients.
    Frusic-Zlotkin M; Pergamentz R; Michel B; David M; Mimouni D; Brégégère F; Milner Y
    Ann N Y Acad Sci; 2005 Jun; 1050():371-9. PubMed ID: 16014554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcellular localization of desmosomal components is different between desmoglein3 knockout mice and pemphigus vulgaris model mice.
    Saito H; Shimizu A; Tsunoda K; Amagai M; Ishiko A
    J Dermatol Sci; 2009 Aug; 55(2):108-15. PubMed ID: 19525093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum of patients with oral pemphigus vulgaris impairs keratinocyte wound repair in vitro: a time-lapse study on the efficacy of methylprednisolone and pyridostigmine bromide.
    Lanza A; Stellavato A; Heulfe I; Landi C; Gombos F; Cirillo N
    Oral Dis; 2009 Oct; 15(7):478-83. PubMed ID: 19519621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p38MAPK inhibition prevents disease in pemphigus vulgaris mice.
    Berkowitz P; Hu P; Warren S; Liu Z; Diaz LA; Rubenstein DS
    Proc Natl Acad Sci U S A; 2006 Aug; 103(34):12855-60. PubMed ID: 16908851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plakoglobin-dependent disruption of the desmosomal plaque in pemphigus vulgaris.
    de Bruin A; Caldelari R; Williamson L; Suter MM; Hunziker T; Wyder M; Müller EJ
    Exp Dermatol; 2007 Jun; 16(6):468-75. PubMed ID: 17518986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
    Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
    Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins.
    Wang X; Brégégère F; Frusić-Zlotkin M; Feinmesser M; Michel B; Milner Y
    Apoptosis; 2004 Mar; 9(2):131-43. PubMed ID: 15004510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis.
    Oktarina DA; van der Wier G; Diercks GF; Jonkman MF; Pas HH
    Br J Dermatol; 2011 Sep; 165(3):552-62. PubMed ID: 21692763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protease inhibitors prevent plasminogen-mediated, but not pemphigus vulgaris-induced, acantholysis in human epidermis.
    Schuh T; Besch R; Braungart E; Flaig MJ; Douwes K; Sander CA; Magdolen V; Probst C; Wosikowski K; Degitz K
    Biol Chem; 2003 Feb; 384(2):311-5. PubMed ID: 12675525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenic human monoclonal antibody against desmoglein 3.
    Yeh SW; Cavacini LA; Bhol KC; Lin MS; Kumar M; Duval M; Posner MR; Ahmed AR
    Clin Immunol; 2006 Jul; 120(1):68-75. PubMed ID: 16635589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis.
    Lee HE; Berkowitz P; Jolly PS; Diaz LA; Chua MP; Rubenstein DS
    J Biol Chem; 2009 May; 284(18):12524-32. PubMed ID: 19270308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests.
    Kamiya K; Aoyama Y; Yamaguchi M; Ukida A; Mizuno-Ikeda K; Fujii K; Hamada T; Tokura Y; Iwatsuki K
    J Dermatol; 2015 Jun; 42(6):572-9. PubMed ID: 25832452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.